Literature DB >> 3692332

Systemic concentrations of metronidazole and its main metabolites after intravenous oral and vaginal administration.

B Fredricsson1, B Hagström, C E Nord, A Rane.   

Abstract

Metronidazole kinetics was studied in 5 healthy women after a single dose given intravenously, orally or vaginally, 500, 400 and 500 mg, respectively. Serum levels of the drug and of its hydroxy and acid metabolites were assessed. The results after intravenous and oral boluses were consistent with previous reports. After vaginal dose maximum serum levels of about 1 microgram/ml of the drug were obtained between 9 and 24 h after the dose. Maximum concentration of the hydroxy metabolite was about 0.3 microgram/ml after 24 h. Bioavailability of the drug was 19 +/- 3% after the vaginal dose as compared to 100 +/- 5% after the oral dose. Daily insertion into the vagina of 500 mg metronidazole resulted in a maximum serum concentration of 1.2 +/- 0.2 microgram/ml of the parent drug and of 0.6 +/- 0.1 microgram/ml of the hydroxy metabolite after about 3 days (range 2-4) after which no accumulation was noted. Urinary excretion of the metabolites was considerably lower after vaginal than after intravenous or oral administration, but the proportion between the two metabolites in the urine was constant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3692332     DOI: 10.1159/000298803

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

Review 1.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

3.  Antibiotic consideration in bacterial vaginosis.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

Review 4.  Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review.

Authors:  A M Wain
Journal:  Infect Dis Obstet Gynecol       Date:  1998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.